Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics

Published:2015-06-22 Issue:1 Volume:32 Page:21-39
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Pozzilli Paolo¹,Battelino Tadej²³,Danne Thomas⁴,Hovorka Roman⁵,Jarosz‐Chobot Przemyslawa⁶,Renard Eric⁷

Affiliation:

1. Area of Endocrinology and Diabetes University Campus Bio‐Medico Rome Italy

2. Department of Endocrinology, Diabetes and Metabolic Diseases University Children's Hospital Ljubljana Ljubljana Slovenia

3. Faculty of Medicine University of Ljubljana Ljubljana Slovenia

4. Diabetes Centre for Children and Adolescents AUF DER BULT, Kinder‐ und Jugendkrankenhaus Hannover Germany

5. Wellcome Trust‐MRC Institute of Metabolic Science University of Cambridge Cambridge UK

6. Department of Pediatrics, Endocrinology and Diabetes School of Medicine in Katowice Medical University of Silesia Katowice Poland

7. Department of Endocrinology, Diabetes, Nutrition and CIC INSERM 1411 Montpellier University Hospital Montpellier France

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.2653

Reference140 articles.

1. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

2. Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes

3. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus;Anonymous, the Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

4. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Anonymous, the UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

5. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Type 1 Diabetes Mellitus Management in Children;Cureus;2024-08-21

2. Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial;Kidney Medicine;2024-08

3. MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method;Health and Quality of Life Outcomes;2024-06-13

4. Development of a hydroxypropyl methyl cellulose/polyacrylic acid interpolymer complex formulated buccal mucosa adhesive film to facilitate the delivery of insulin for diabetes treatment;International Journal of Biological Macromolecules;2024-06

5. Results of biosimilar assessing of insulin aspart preparations of Russian and foreign production using the hyperinsulinemic euglycemic clamp method and studying the use of a new ultra-fast-acting Russian biosimilar in pumps;Meditsinskiy sovet = Medical Council;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3